 Editas Medicine, Inc. NASDAQ:EDIT EDIT-301 Clinical Update Call December 6, 2022 8:00 AM ET Company Participants Ron Moldaver - Investor Relations Gilmore ONeill - President and Chief Executive Officer Baisong Mei - Senior Vice President and Chief Medical Officer Mark Shearman - Chief Scientific Officer Conference Call Participants Phil Nadeau - Cowen Securities Gena Wang - Barclays Matthew Harrison - Morgan Stanley Joon Lee - Truist Securities Joel Beatty - Baird Greg Harrison - BofA Yanan Zhu - Wells Fargo Steven Seedhouse - Raymond James Dae Gon Ha - Stifel Mani Foroohar - SVB Ron Moldaver Good morning, everyone, and thank you for joining the EDIT-301 Clinical Update Webinar. This webinar is being recorded and can be accessed in the future through the same link or through the Investors section of the companys website. 